Distinguishing Acute Liver Failure from Decompensated Cirrhosis
The fundamental distinction is the presence or absence of pre-existing chronic liver disease: acute liver failure occurs in patients WITHOUT underlying cirrhosis, while decompensated cirrhosis represents complications arising in patients WITH established chronic liver disease. 1, 2
Key Distinguishing Features
Acute Liver Failure (ALF)
- No pre-existing cirrhosis or chronic liver disease 1, 2
- Rapid onset of hepatocyte injury evolving over days to weeks
- Characterized by:
- Elevated aminotransferases (often markedly elevated)
- Coagulopathy (INR ≥1.5)
- Altered mentation/encephalopathy
- Duration of illness ≤26 weeks 1
- Common causes: acetaminophen toxicity, hepatic ischemia, viral hepatitis, autoimmune hepatitis, drug-induced liver injury 2
- Physical exam: absence of stigmata of chronic liver disease is critical 1
Decompensated Cirrhosis
- Pre-existing chronic liver disease or cirrhosis is present 3
- Development of overt clinical complications including:
- Ascites
- Hepatic encephalopathy
- Variceal bleeding
- Jaundice 3
- Progressive course over months to years
- Physical exam: stigmata of chronic liver disease typically present (spider angiomata, palmar erythema, splenomegaly)
The Critical Third Entity: Acute-on-Chronic Liver Failure (ACLF)
ACLF represents a distinct syndrome that bridges these two conditions and must not be confused with either pure ALF or simple decompensated cirrhosis. 4, 5
ACLF Diagnostic Criteria (AASLD 2024)
ACLF requires ALL three of the following elements 4:
- Acute onset with rapid deterioration in clinical condition
- Liver failure defined by elevated bilirubin AND elevated INR in patients with chronic liver disease (with or without cirrhosis)
- At least one extrahepatic organ failure (neurologic, circulatory, respiratory, or renal)
ACLF vs. Simple Decompensated Cirrhosis
- ACLF: 28-day mortality 20-50% 5
- Decompensated cirrhosis without ACLF: 28-day mortality ≤5% 5
- The presence of extrahepatic organ failure is the critical distinguishing feature 4, 5
Clinical Algorithm for Differentiation
Step 1: Establish Chronicity
- History of cirrhosis or chronic liver disease?
- NO → Consider acute liver failure
- YES → Proceed to Step 2
Step 2: Assess for Stigmata of Chronic Disease
- Spider angiomata, palmar erythema, splenomegaly, collateral vessels?
- Absent → Favors ALF (but obtain imaging to exclude occult cirrhosis)
- Present → Confirms chronic liver disease
Step 3: Evaluate Organ Dysfunction Pattern
- Single organ (liver only) with coagulopathy + encephalopathy + NO cirrhosis → ALF
- Liver complications (ascites, encephalopathy, bleeding) WITHOUT extrahepatic organ failure + cirrhosis → Decompensated cirrhosis
- Liver failure + ≥1 extrahepatic organ failure + rapid deterioration + cirrhosis → ACLF 4
Common Pitfalls
Assuming all jaundiced patients with encephalopathy have ALF: Always search for stigmata of chronic disease and obtain detailed history regarding alcohol use, viral hepatitis, or prior liver disease 1
Confusing ACLF with ALF: The presence of underlying chronic liver disease definitively excludes pure ALF 2
Missing occult cirrhosis: Some patients present with their first decompensation without known prior liver disease—imaging and careful examination are essential 3
Applying ALF prognostic criteria to ACLF or decompensated cirrhosis: These are distinct entities requiring different prognostic tools 1
Laboratory Cutoffs (Context-Dependent)
- ALF: INR ≥1.5 with encephalopathy and no cirrhosis 1
- ACLF: Variable definitions exist (INR 1.5-2.5, bilirubin 5-12 mg/dL depending on criteria used), but extrahepatic organ failure is mandatory 4
The absence of pre-existing liver disease is the single most important historical feature distinguishing ALF from all cirrhosis-related syndromes, while the presence of extrahepatic organ failure distinguishes ACLF from simple decompensated cirrhosis. 1, 2, 4